FirsthandHealth
medRxiv PreprintsInternational4 November 2026

Olfactory Function in Preclinical Alzheimer's Disease: A Multi-Cohort Study

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

Introduction: Olfactory impairment is an early feature of Alzheimer's disease (AD). However, it is unclear if olfactory performance reflects early pathological changes during preclinical AD and/or predicts subsequent clinical progression among characterized cognitively normal (CN) individuals. We aimed to determine whether odor identification differs by amyloid status, relates to medial temporal lobe (MTL) tau burden and morphometry, and predicts longitudinal conversion to mild cognitive impairment (MCI). Methods: We analyzed data from 257 cognitively normal (CN) older adults enrolled in PREVE
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.